ライフサイエンスコーパス: calcitonin gene-related peptide

1 increased labelling of neuronal profiles for calcitonin gene related peptide.

2 geted for anti-tyrosine hydroxylase and anti-calcitonin gene-related peptide.

3 matostatin, nefstatin-1, interleukin-11, and calcitonin gene-related peptide.

4 lar motoneurons, are also immunoreactive for calcitonin gene-related peptide.

5 ltaneous immunostaining for the neuropeptide calcitonin gene-related peptide.

6 sociated induction of c-Fos and depletion of calcitonin gene-related peptide.

7 9.5, growth associated protein 43, trkA, and calcitonin gene-related peptide.

8 nociceptive peptides such as substance P and calcitonin gene-related peptide.

9 n was driven by the nociceptive neuropeptide calcitonin gene-related peptide.

10 sin I, SV2, or syntaxin and the neuropeptide calcitonin gene-related peptide.

11 ion of terminals within the VPMpc containing calcitonin gene-related peptide.

12 Microiontophoresis of calcitonin gene-related peptide 8-37 also showed a signi

13 related peptide and the receptor antagonists calcitonin gene-related peptide 8-37 and olcegepant on t

14 The expression of calcitonin gene-related peptide, a marker for peptidergi

15 Calcitonin gene-related peptide, adrenomedullin, amylin,

16 d that pIII glutamatergic neurons expressing calcitonin gene-related peptide alpha (CALCA) are NREM-s

17 Deletion or silencing of calcitonin-gene-related peptide alpha (alphaCGRP) gene e

18 arch into the therapeutic potential of alpha-calcitonin gene-related peptide (alpha-CGRP) has been li

19 of exon 5 of Calca, which encodes the alpha-calcitonin gene-related peptide (alpha-CGRP), in intesti

20 or 5 min) and by infusion for 5 min of alpha-calcitonin gene-related peptide (alpha-CGRP), which are

21 s, increased hippocampal expression of alpha calcitonin gene-related peptide (alphaCGRP) transcripts,

22 Intravenous alpha-calcitonin gene-related peptide (alphaCGRP)(8-37) produc

23 onic levels of the inflammatory neuropeptide calcitonin-gene-related peptide, although inflammatory i

24 Biological agents to treat pain (anti-calcitonin gene-related peptide and anti-nerve growth fa

25 ted, and lost immunodetectable expression of calcitonin gene-related peptide and capsaicin receptors,

26 d and thin myelinated afferents labeled with calcitonin gene-related peptide and isolectin B4, and in

27 Many colocalize with calcitonin gene-related peptide and isolectin B4, and th

28 eptides that modulate LC function, including calcitonin gene-related peptide and pituitary adenylate

29 pression of mu opioid receptor and increased calcitonin gene-related peptide and substance P immunore

30 is an axon reflex, which may be mediated by calcitonin gene-related peptide and substance P released

31 peptidergic nociceptive fibers (positive for calcitonin gene-related peptide and substance P) and mye

32 n the adult spinal cord reduced sprouting of calcitonin gene-related peptide and substance P-containi

33 ther tested the effect of microiontophoresed calcitonin gene-related peptide and the receptor antagon

34 subset of sensory neurons that colabel with calcitonin gene-related peptide and TRPV1 suggestive of

35 and cOv are characterized with expression of calcitonin-gene-related peptide and cholecystokinin.

36 omatostatin, gastric inhibitory polypeptide, calcitonin gene-related peptide, and adrenomedullin.

37 apsaicin measured by (Ca(2+))(i), release of calcitonin gene-related peptide, and inward currents.

38 l peptidergic neuron markers substance P and calcitonin gene-related peptide, and the nonpeptidergic

39 ensory axons expressing Phox2b, substance P, calcitonin-gene related peptide, and the serotonin recep

40 aine, including sumatriptan, naproxen, and a calcitonin gene-related peptide antagonist.

41 staltic transmitters 5-hydroxytryptamine and calcitonin gene-related peptide; antagonists of these tr

42 assess the safety and efficacy of monoclonal calcitonin gene-related peptide antibodies for the preve

43 Variants of the calcitonin gene-related peptide artificially activate va

44 e fly homolog of the vertebrate neuropeptide calcitonin gene-related peptide, as a circadian wake-pro

45 modicum of investment, new targets, such as calcitonin gene-related peptide-based mechanisms, and en

46 ADA reduces blood levels of the neuropeptide calcitonin gene-related peptide but increases the neurop

47 AMP-dependent secretion of IL-1beta and beta-calcitonin gene-related peptide by dendritic cells.

48 ng protein 1 (RAMP1) comprise a receptor for calcitonin gene related peptide (CGRP) and intermedin.

49 ion induced by the Katp agonists cromakalim, calcitonin gene related peptide (CGRP) and the Kca agoni

50 mediating sensory neuropeptides galanin and calcitonin gene related peptide (CGRP) in a model of neu

51 The calcitonin gene related peptide (CGRP) pathway is import

52 mouse bone induces a remarkable sprouting of calcitonin gene-related peptide (CGRP(+)) and neurofilam

53 ronal marker PGP9.5 and specific markers for calcitonin gene-related peptide (CGRP) (sensory C and A

54 Here, we report that calcitonin gene-related peptide (CGRP) activates CFTR-de

55 ing site of the homologous receptors for the calcitonin gene-related peptide (CGRP) and adrenomedulin

56 nables selective recognition of the peptides calcitonin gene-related peptide (CGRP) and adrenomedulli

57 ed receptors involved in energy homeostasis: calcitonin gene-related peptide (CGRP) and amylin recept

58 rleukin (IL)-5, together with Calca-encoding calcitonin gene-related peptide (CGRP) and its cognate r

59 w that ILC2s expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor.

60 afferents with capsaicin, and antagonism of calcitonin gene-related peptide (CGRP) and neurokinin-1

61 asodilation that depends upon the release of calcitonin gene-related peptide (CGRP) and nitric oxide

62 s for the treatment of acute migraine target calcitonin gene-related peptide (CGRP) and serotonin (5-

63 and/or ARs lead to release of neuropeptides calcitonin gene-related peptide (CGRP) and substance P (

64 irst evidence that antisera directed against calcitonin gene-related peptide (CGRP) and substance P c

65 gic small-diameter primary afferent markers, calcitonin gene-related peptide (CGRP) and the lectin IB

66 expression of the potent vasoactive agents' calcitonin gene-related peptide (CGRP) and vascular endo

67 of asymmetric axosomatic synapses containing calcitonin gene-related peptide (CGRP) and vGluT2.

68 However, the A11 does contain dopamine and calcitonin gene-related peptide (CGRP) and, by this comb

69 ntibody and double stained with chicken anti-calcitonin gene-related peptide (CGRP) antibody.

70 It has been proposed that substance P and calcitonin gene-related peptide (CGRP) are upregulated i

71 al studies have established the neuropeptide calcitonin gene-related peptide (CGRP) as a key player i

72 elevant and recent studies on the biology of calcitonin gene-related peptide (CGRP) as it pertains to

73 ntly suppressed basal neuronal expression of calcitonin gene-related peptide (CGRP) as well as stimul

74 Acetylcholine and calcitonin gene-related peptide (CGRP) cause vasodilatio

75 Calcitonin gene-related peptide (CGRP) co-internalizes w

76 Calcitonin gene-related peptide (CGRP) evokes anxiety-li

77 The calcitonin gene-related peptide (CGRP) family of G prote

78 evoked a concentration-dependent release of calcitonin gene-related peptide (CGRP) from cultured rat

79 pain, inhibited release of the neuropeptide calcitonin gene-related peptide (CGRP) from dorsal root

80 CIM0216 elicited the release of the peptides calcitonin gene-related peptide (CGRP) from sensory nerv

81 The neuropeptide calcitonin gene-related peptide (CGRP) from the trigemin

82 ovided strong evidence that the neuropeptide calcitonin gene-related peptide (CGRP) has a key role in

83 Calcitonin gene-related peptide (CGRP) has been implicat

84 emale-biased disorder.SIGNIFICANCE STATEMENT Calcitonin gene-related peptide (CGRP) has long been imp

85 The role of calcitonin gene-related peptide (CGRP) in cardiovascular

86 usion of neural factors, norepinephrine, and calcitonin gene-related peptide (CGRP) in denervated kid

87 The pivotal role of calcitonin gene-related peptide (CGRP) in migraine patho

88 sic science data support an integral role of calcitonin gene-related peptide (CGRP) in migraine patho

89 y of evidence supports an important role for calcitonin gene-related peptide (CGRP) in migraine patho

90 t, accumulating evidence supports a role for calcitonin gene-related peptide (CGRP) in the activation

91 This study determined the role of calcitonin gene-related peptide (CGRP) in the maintenanc

92 Here, we show that neurons expressing calcitonin gene-related peptide (CGRP) in the parabrachi

93 ody of evidence points to a critical role of calcitonin gene-related peptide (CGRP) in the pathophysi

94 Neurons containing the neuropeptide calcitonin gene-related peptide (CGRP) increased in sens

95 In contrast with this, infusion of calcitonin gene-related peptide (CGRP) into BNST was rep

96 Calcitonin gene-related peptide (CGRP) is a 37-residue n

97 SIGNIFICANCE STATEMENT: The neuropeptide calcitonin gene-related peptide (CGRP) is a central play

98 Calcitonin gene-related peptide (CGRP) is a classic mole

99 Calcitonin gene-related peptide (CGRP) is a key element

100 The neuropeptide calcitonin gene-related peptide (CGRP) is a key player i

101 Calcitonin gene-related peptide (CGRP) is a neuropeptide

102 Calcitonin gene-related peptide (CGRP) is a nonadrenergi

103 Calcitonin gene-related peptide (CGRP) is a potent arter

104 Calcitonin gene-related peptide (CGRP) is a potent neuro

105 Calcitonin gene-related peptide (CGRP) is a potent vasod

106 Calcitonin gene-related peptide (CGRP) is a sensory neur

107 Calcitonin gene-related peptide (CGRP) is a validated ta

108 The neuropeptide calcitonin gene-related peptide (CGRP) is associated wit

109 Calcitonin gene-related peptide (CGRP) is crucial in the

110 Calcitonin gene-related peptide (CGRP) is involved in a

111 ed immunoabsorbent assay was used to measure calcitonin gene-related peptide (CGRP) levels in blood.

112 inase and estrogen receptor (CreER) into the calcitonin gene-related peptide (CGRP) locus that encode

113 very migraine patient.SIGNIFICANCE STATEMENT Calcitonin gene-related peptide (CGRP) monoclonal antibo

114 the contribution to cancer anorexia made by calcitonin gene-related peptide (CGRP) neurons in the pa

115 Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor h

116 Calcitonin gene-related peptide (CGRP) pathway inhibitor

117 The calcitonin gene-related peptide (CGRP) pathway is a prom

118 The calcitonin gene-related peptide (CGRP) pathway is import

119 The neuropeptide calcitonin gene-related peptide (CGRP) plays a critical

120 Among these neuropeptides, calcitonin gene-related peptide (CGRP) plays a prominent

121 romote the nonneuronal pathway of calcitonin/calcitonin gene-related peptide (CGRP) pre-mRNA processi

122 of alternative processing of the calcitonin/calcitonin gene-related peptide (CGRP) pre-mRNA, the mec

123 Calcitonin gene-related peptide (CGRP) probably has a ro

124 We have examined the regulation of calcitonin gene-related peptide (CGRP) promoter activity

125 Calcitonin gene-related peptide (CGRP) receptor antagoni

126 Calcitonin gene-related peptide (CGRP) receptor antagoni

127 sign enabled the discovery of 8, HTL22562, a calcitonin gene-related peptide (CGRP) receptor antagoni

128 t is an orally administered, small-molecule, calcitonin gene-related peptide (CGRP) receptor antagoni

129 Calcitonin gene-related peptide (CGRP) receptor blockade

130 X: an ultrapotent analog of capsaicin) and a calcitonin gene-related peptide (CGRP) receptor blocker

131 The calcitonin gene-related peptide (CGRP) receptor is a het

132 fying proteins (RAMP) to become a functional calcitonin gene-related peptide (CGRP) receptor or an ad

133 component of several receptors including the calcitonin gene-related peptide (CGRP) receptor.

134 ctivity modifying protein (RAMP) 1 to give a calcitonin gene-related peptide (CGRP) receptor.

135 unds abolished the enhanced capsaicin-evoked calcitonin gene-related peptide (CGRP) release and dynor

136 eover NO increased neuronal excitability and calcitonin gene-related peptide (CGRP) release and these

137 PA1-selective agonist, mustard oil (MO), for calcitonin gene-related peptide (CGRP) release from rat

138 idine (CLON) or their combination to inhibit calcitonin gene-related peptide (CGRP) release from spin

139 rmacologic inhibition of substance P (SP) or calcitonin gene-related peptide (CGRP) signaling in Vglu

140 pharmacological inhibition of substance P or calcitonin gene-related peptide (CGRP) signaling in Vglu

141 had no effect on acanthosis; restoration of calcitonin gene-related peptide (CGRP) signaling reverse

142 DCN A and C fibers and their relationship to calcitonin gene-related peptide (CGRP) staining in the d

143 Calcitonin gene-related peptide (CGRP) stimulated CLR en

144 s depend, in part, on its ability to release calcitonin gene-related peptide (CGRP) through an uniden

145 els of migraine, we show that application of calcitonin gene-related peptide (CGRP) to the rat dura m

146 P 55,940 on depolarization-evoked release of calcitonin gene-related peptide (CGRP) were compared.

147 antibodies against VGLUT(1) , VGLUT(2) , and calcitonin gene-related peptide (CGRP) were used.

148 G-protein-coupled receptors (GPCR) and bind calcitonin gene-related peptide (CGRP) with similar affi

149 sal root ganglia (DRG), some neurons express calcitonin gene-related peptide (CGRP) without substance

150 - and large-sized neurons immunoreactive for calcitonin gene-related peptide (CGRP), a marker for pep

151 y trigeminal nerve fibers immunoreactive for calcitonin gene-related peptide (CGRP), a marker for pol

152 that reacted with a labeled antibody against calcitonin gene-related peptide (CGRP), a marker of noci

153 ceptors directly respond to STm by releasing calcitonin gene-related peptide (CGRP), a neuropeptide t

154 Calcitonin gene-related peptide (CGRP), adrenomedullin (

155 tor (CLR) for calcitonin (CT), amylin (Amy), calcitonin gene-related peptide (CGRP), and adrenomedull

156 ated with nerves containing the neuropeptide calcitonin gene-related peptide (CGRP), and CGRP inhibit

157 rves induced production of the neuropeptide, calcitonin gene-related peptide (CGRP), and CGRP treatme

158 ron somata, especially those also expressing calcitonin gene-related peptide (CGRP), and in central p

159 colocalization of EM2 with substance P (SP), calcitonin gene-related peptide (CGRP), and MOR in prima

160 ypes that express neurofilament (NF) 200 and calcitonin gene-related peptide (CGRP), and that these n

161 The relative numbers of neurons containing calcitonin gene-related peptide (CGRP), cocaine- and amp

162 T), vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP), galanin (GAL), a

163 ed transcript (cart), cholecystokinin (cck), calcitonin gene-related peptide (cgrp), galanin, hypocre

164 b, a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), is being investi

165 DRG) neurons with PAR2, substance P (SP) and calcitonin gene-related peptide (CGRP), mediators of pai

166 t the fusion of a RAMP1 co-receptor with the calcitonin gene-related peptide (CGRP), or calcitonin, t

167 reactive (IR) for neurofilament 200 (N52) or calcitonin gene-related peptide (CGRP), or labeled by is

168 The neuropeptides calcitonin gene-related peptide (CGRP), pituitary adenyl

169 g either isolectin B4 (IB4) or antibodies to calcitonin gene-related peptide (CGRP), respectively.

170 characterized by using six neuronal markers: calcitonin gene-related peptide (CGRP), substance P (SP)

171 ytochemical studies combined CTb with either calcitonin gene-related peptide (CGRP), substance P (SP)

172 clonal antibodies for class II beta-tubulin, calcitonin gene-related peptide (CGRP), substance P (SP)

173 did not colocalize with the C-fiber markers calcitonin gene-related peptide (CGRP), substance P, and

174 Calcitonin gene-related peptide (CGRP), the most abundan

175 n exists between migraine and release of the calcitonin gene-related peptide (CGRP), the possibility

176 the PBel neurons that respond to CO2 express calcitonin gene-related peptide (CGRP), we hypothesized

177 ological states, we injected the vasodilator calcitonin gene-related peptide (CGRP), which induces he

178 lly no double staining was found for NR1 and calcitonin gene-related peptide (CGRP), which labels som

179 nerve fibers innervating taste buds contain calcitonin gene-related peptide (CGRP), which may be as

180 focuses on the topographical distribution of calcitonin gene-related peptide (CGRP)-containing cell b

181 We show that a subset of adult calcitonin gene-related peptide (CGRP)-expressing myente

182 In contrast, calcitonin gene-related peptide (CGRP)-expressing neuron

183 Previously, we identified calcitonin gene-related peptide (CGRP)-expressing neuron

184 afferent neurons are almost exclusively non-calcitonin gene-related peptide (CGRP)-immunoreactive (-

185 Post-traumatic sprouting of calcitonin gene-related peptide (CGRP)-immunoreactive pr

186 ave shown previously that estrogen increases calcitonin gene-related peptide (CGRP)-immunoreactive se

187 as to identify the location, morphology, and calcitonin gene-related peptide (CGRP)-immunoreactivity

188 ha-3 (GFRalpha3)-positive neurons (67%), and calcitonin gene-related peptide (CGRP)-positive neurons(

189 eads to robust regeneration and sprouting of calcitonin gene-related peptide (CGRP)-positive nocicept

190 nduced HSC mobilization via the secretion of calcitonin gene-related peptide (CGRP).

191 ct contact with peripheral neurons secreting calcitonin gene-related peptide (CGRP).

192 ession of protein gene product (PGP) 9.5 and calcitonin gene-related peptide (CGRP).

193 ng protein 1 (RAMP1) comprise a receptor for calcitonin gene-related peptide (CGRP).

194 l pulp regulate capsaicin-induced release of calcitonin gene-related peptide (CGRP).

195 in-releasing peptide (GRP), substance P, and calcitonin gene-related peptide (CGRP).

196 ty for neuropeptide Y (NPY), calretinin, and calcitonin gene-related peptide (CGRP).

197 nd and binds to the same receptors as AM and calcitonin gene-related peptide (CGRP).

198 le axons and nerve endings immunoreactive to calcitonin gene-related peptide (CGRP).

199 , corticotrophin releasing hormone (CRH) and calcitonin gene-related peptide (CGRP).

200 in Old MAs along with impaired dilatation to calcitonin gene-related peptide (CGRP).

201 ophagus were removed, fixed, and stained for calcitonin gene-related peptide (CGRP).

202 of the membrane based on their expression of calcitonin gene-related peptide (CGRP).

203 and a population of cisplatin-activated lPBN calcitonin gene-related peptide (CGRP, a marker for glut

204 Gene expression of the neuropeptides calcitonin gene-related peptide (CGRP-alpha) and substan

205 hinly myelinated and unmyelinated fibers) or calcitonin gene-related peptide (CGRP; a marker more typ

206 ochemistry analysis using antibodies against calcitonin gene-related peptide (CGRP; sensory nerve fib

207 Benefits of calcitonin-gene related peptide (CGRP) inhibition have n

208 The neuroactive peptide calcitonin-gene related peptide (CGRP) is known to act a

209 the lateral parabrachial nucleus (lPBN) and calcitonin-gene related peptide (CGRP) projections from

210 des vasoactive intestinal polypeptide (VIP), calcitonin-gene related peptide (CGRP), substance P (SP)

211 amus (PVN; p<0.05) as well as an increase in calcitonin-gene related peptide (CGRP; p<0.05, one taile

212 knowledge, between the internal dynamics of calcitonin-gene-related peptide (CGRP) and amylin (islet

213 express both IL-33 and the receptor for the calcitonin-gene-related peptide (CGRP); and demonstrate

214 f rat spinal sensory afferents identified by Calcitonin-Gene-Related-Peptide (CGRP) for peptidergic t

215 sh-fixed and stained for immunoreactivity to calcitonin-gene-related-peptide (CGRP).

216 port the importance of the G-protein-coupled calcitonin gene-related peptide (CGRP1) receptor as a cr

217 adenylate cyclase-activating polypeptide and calcitonin gene-related peptide, down-regulates LC funct

218 circular muscle and release of serotonin and calcitonin gene-related peptide during the peristaltic r

219 istaltic reflex and release of serotonin and calcitonin gene-related peptide during the peristaltic r

220 ide, but was induced by aristolochic acid I, calcitonin gene-related peptide, endothelin-1, gentamici

221 born dopaminergic, GABAergic, nitrergic, and calcitonin gene-related peptide-expressing neurons and a

222 Here we identify calcitonin gene-related peptide-expressing neurons in th

223 in trigeminal sensory afferents, increasing calcitonin gene-related peptide expression and basal tri

224 42, a fully humanised monoclonal antibody to calcitonin gene-related peptide, for migraine prevention

225 een confirmed, and the subsequent release of calcitonin gene-related peptide from a mouse heart has b

226 capsaicin-induced release of substance P and calcitonin gene-related peptide from superfused segments

227 stimulatory role of Foxa2 at the calcitonin/calcitonin gene-related peptide gene enhancer was confir

228 s cell-specific expression of the calcitonin/calcitonin gene-related peptide gene.

229 onsible for other neurotransmitters, such as calcitonin gene-related peptide, histamine, and dopamine

230 Here, we used stimulated immunoreactive Calcitonin Gene-Related Peptide (iCGRP) release as a mea

231 2 (PGE2; 1 microm)-stimulated immunoreactive calcitonin gene-related peptide (iCGRP) release or PGE2

232 apoptosis, and release of the immunoreactive calcitonin gene-related peptide (iCGRP).

233 Calcitonin gene-related peptide immunolabeled (peptiderg

234 dult mice, MET was restricted to a subset of calcitonin gene-related peptide-immunoreactive (IR) myen

235 Calcitonin gene-related peptide-immunoreactive sensory i

236 ry afferent terminal markers isolectin B4 or calcitonin-gene-related peptide immunoreactivity.

237 ated release of the neuropeptide transmitter calcitonin gene-related peptide in mouse DRG neurons.

238 lease of the sensory mediators serotonin and calcitonin gene-related peptide in rat colon.

239 es in the skin and reduction of neuropeptide calcitonin gene-related peptide in the dorsal horn of sp

240 evention and provide support for the role of calcitonin gene-related peptide in the pathogenesis of m

241 vascular activation, including expression of calcitonin gene-related peptide in the trigeminal gangli

242 GFI1 colocalizes with chromogranin A and calcitonin-gene-related peptide in embryonic and adult m

243 As for sensory axons (immunostained for calcitonin gene-related peptide) in the urinary bladders

244 and efficacy of galcanezumab, an antibody to calcitonin gene-related peptide, in patients with migrai

245 ng factor, thyrotropin-releasing hormone and calcitonin gene-related peptide) involved in the mediati

246 Substance P immunoreactive (-ir) and calcitonin gene related peptide-ir (CGRP-ir) were virtua

247 coexpressed with tyrosine hydroxylase-IR or calcitonin gene-related peptide-IR fibers.

248 y, accompanied by increased axonal growth of calcitonin gene-related peptide-labeled fibers in the do

249 cetylcholine, somatostatin, cholecystokinin, calcitonin gene-related peptide, leptin, and parietal ce

250 anezumab, a humanized monoclonal antibody to calcitonin gene-related peptide, may be a preventive tre

251 The potent vasodilator calcitonin gene-related peptide mediates neurogenic infl

252 d alter alternative splicing of a calcitonin/calcitonin gene-related peptide minigene in a hormone-de

253 E11.5, followed by neurofilament-M neurons, calcitonin gene-related peptide neurons (peak cell cycle

254 alphaCGRP (alpha calcitonin gene-related peptide), one of the strongest v

255 imary afferent (C fiber) origin, stained for calcitonin gene-related peptide or isolectin B4, but non

256 nt differences were observed in substance P, calcitonin gene-related peptide, or neuropeptide Y prote

257 teral parabrachial nucleus (PBel) containing calcitonin gene related peptide (PBel(CGRP) neurons) are

258 ased the density of PGP9.5-positive, but not calcitonin gene-related peptide-positive, free nerve end

259 etrogradely labeled neurons from the DP were calcitonin-gene-related-peptide-positive (peptide-expres

260 Regenerated unmyelinated axons expressing calcitonin gene-related peptide project only to superfic

261 ibers were predominant (tyrosine hydroxylase/calcitonin gene-related peptide ratio 25.1 +/- 33.4; p <

262 ric synthesis of the major metabolite of the calcitonin gene-related peptide recepotor antagonist BMS

263 nputs and tested the effect of olcegepant, a calcitonin gene-related peptide receptor antagonist (1 m

264 Ubrogepant is an oral, small-molecule calcitonin gene-related peptide receptor antagonist for

265 Treatment of a migraine attack with the oral calcitonin gene-related peptide receptor antagonist rime

266 Rimegepant is a calcitonin gene-related peptide receptor antagonist that

267 t is an orally administered, small-molecule, calcitonin gene-related peptide receptor antagonist that

268 Ubrogepant is an oral calcitonin gene-related peptide receptor antagonist unde

269 Rimegepant, a small molecule calcitonin gene-related peptide receptor antagonist, has

270 While it has been demonstrated that calcitonin gene-related peptide receptor antagonists act

271 Calcitonin gene-related peptide receptor antagonists are

272 This is the first report on the efficacy of calcitonin gene-related peptide receptor antagonists at

273 pathway, showing that the central effects of calcitonin gene-related peptide receptor antagonists ext

274 : 5-HT1F receptor agonists, and the gepants: calcitonin gene-related peptide receptor antagonists, in

275 uture non-vasoconstrictor approaches include calcitonin gene-related peptide receptor antagonists.

276 Calcitonin gene-related peptide receptor has been implic

277 ore used to migraine, such as naproxen and a calcitonin gene-related peptide receptor inhibitor, olce

278 nucleus by specifically co-staining for the calcitonin gene-related peptide receptor subunits calcit

279 human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, for the preven

280 e presence of the components of a functional calcitonin gene-related peptide receptor, the calcitonin

281 ain G-protein-coupled receptors, such as the calcitonin gene-related peptide receptor, to the plasma

282 while a CRLR heterodimer with RAMP1 yields a calcitonin gene-related peptide receptor.

283 ng to demonstrate the presence of functional calcitonin gene-related peptide receptors in the ventrop

284 Because the sensory neuropeptide CGRP (calcitonin gene-related peptide) regulates host response

285 hypothesis by measuring capsaicin-stimulated calcitonin gene-related peptide release (CGRP) as a meas

286 tch-clamp electrophysiology, Ca(2+) imaging, calcitonin gene-related peptide release assay from tissu

287 currents, calcium influx, and immunoreactive calcitonin gene-related peptide release from cultured TG

288 icin-evoked nocifensive responses, increased calcitonin gene-related peptide release from hindpaw ski

289 vation by icilin blocked capsaicin-triggered calcitonin-gene-related peptide release from colon tissu

290 Acute infection activates calcitonin gene-related peptide sensory neurons coupled

291 x by augmenting the release of serotonin and calcitonin gene-related peptide that mediate the sensory

292 ch, in return, allowed endoneurally released calcitonin gene-related peptide to pass through the nerv

293 sine hydroxylase [TH], dopamine transporter, calcitonin gene-related peptide, TrkC).

294 tions of met-enkephalin, vasotocin, galanin, calcitonin gene-related peptide, tyrosine hydroxylase, v

295 1, TRPA1, and neuropeptides (substance P and calcitonin gene-related peptide) using genetic and pharm

296 Calcitonin gene-related peptide, vesicular acetylcholine

297 e two potent vasodilators adrenomedullin and calcitonin gene-related peptide, we tested the effects o

298 istaltic reflex and release of serotonin and calcitonin gene-related peptide were also examined in ge

299 y nerve terminals, triggering the release of calcitonin gene-related peptide which elicits vasorelaxa

300 axons (peripherin-positive axons containing calcitonin gene-related peptide), without changes in sym